Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
or

Springworks Therapeutics Inc (SWTX)

Springworks Therapeutics Inc (SWTX)
46.80 +0.09 (+0.19%) 16:00 ET [NASDAQ]
46.75 x 700 46.84 x 3,500
Realtime by (Cboe BZX)
46.75 x 700 46.84 x 3,500
Realtime 46.80 unch (unch) 16:01 ET
News & Headlines for Thu, Jun 5th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
SpringWorks Gets CHMP Nod for Mirdametinib in Rare Disease

SpringWorks Therapeutics SWTX announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has rendered a positive opinion recommending conditional marketing...

LXRX : 0.7170 (+8.46%)
AMRN : 11.85 (+0.04%)
HALO : 53.55 (-0.56%)
SWTX : 46.80 (+0.19%)
SpringWorks Therapeutics Receives Positive CHMP Opinion for Mirdametinib for the Treatment of Adult and Pediatric Patients with NF1-PN

SWTX : 46.80 (+0.19%)
Plus500 Makes Futures Trading Truly Accessible: Low Margins and Up to $200 in a Commission-Free Bonus!

Trade the most popular US futures of 2025: Agricultural Commodities, Indices, Crypto, Metals, Forex, and more! Join over 30 million people worldwide who trust Plus500. Start trading today with a deposit as low as $100!

SpringWorks Therapeutics: Q1 Earnings Snapshot

SpringWorks Therapeutics: Q1 Earnings Snapshot

SWTX : 46.80 (+0.19%)
Merck KGaA, Darmstadt, Germany to Acquire SpringWorks Therapeutics to Accelerate Sustainable Growth of Healthcare Business

SWTX : 46.80 (+0.19%)
SpringWorks Therapeutics Announces Expected CHMP Opinion in Q2 2025 for Nirogacestat for the Treatment of Adults with Desmoid Tumors in the European Union

SWTX : 46.80 (+0.19%)
Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week

Positive data from clinical trials, earnings readouts, M&A speculation and new research drew heavy interest from retail traders on Stocktwits for these tickers for the week ended March 14, 2025.

TNYA : 0.5400 (+2.53%)
CSCI : 3.72 (unch)
MLYS : 15.62 (+0.64%)
SWTX : 46.80 (+0.19%)
MGX : 1.6600 (-2.35%)
SpringWorks Therapeutics Leads Biotech Pack In Weekly Retail Follower Surge: What's Fueling Interest?

Investor attention is now on whether Merck will confirm a formal offer as speculation over a potential acquisition continues dominating discussions around the stock.

VTI : 291.72 (-0.55%)
XBI : 82.56 (+0.10%)
IWM : 208.54 (+0.05%)
SWTX : 46.80 (+0.19%)
SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Updates

SWTX : 46.80 (+0.19%)
SpringWorks Therapeutics Gains Retail Interest Ahead Of Q4 Earnings – What Investors Expect

Recent investor enthusiasm has been fueled by reports that German healthcare giant Merck KGaA is in advanced talks to acquire SpringWorks.

VTI : 291.72 (-0.55%)
XBI : 82.56 (+0.10%)
IWM : 208.54 (+0.05%)
SWTX : 46.80 (+0.19%)

Barchart Exclusives

Elon Musk’s ‘KILL the BILL’ Sends Tesla Shares Down. Is It Time to Sell TSLA Stock Here?
Tesla shares crater as President Donald Trump says he’s disappointed in Elon Musk. A William Blair analyst remains bullish on TSLA stock. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
The Coil Before the Break: How to Spot and Trade Long-Term Consolidation Patterns